DERMATOLOGIC RELIEF 2 % — DIN 02393344
LIDOCAINE : 2 % ZINC OXIDE : 16 % · JAMP PHARMA CORPORATION · OINTMENT · wholesale supply in Canada
Health Canada status: APPROVED
What is DERMATOLOGIC RELIEF?
DERMATOLOGIC RELIEF 2 % contains LIDOCAINE : 2 % ZINC OXIDE : 16 %. It is listed in the Health Canada Drug Product Database under DIN 02393344, held by JAMP PHARMA CORPORATION, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as approved, status dated 11-Sep-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Lidocaine cost around the world?
Lidocaine is listed on 14 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 25 | 121 | USD███.██ |
| United Kingdom | hospital | 22 | 22 | GBP███.██ |
| United Arab Emirates | public | 11 | 16 | AED███.██ |
| Bahrain | retail (max) | 11 | 14 | BHD███.██ |
| South Africa | single exit price | 7 | 12 | ZAR███.██ |
| Greece | producer price (ex-factory) | 9 | 9 | EUR███.██ |
| Saudi Arabia | public | 6 | 9 | SAR███.██ |
| Morocco | PPV (public price) | 8 | 8 | MAD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 4 | 4 | EUR███.██ |
| Australia | ex-manufacturer | 3 | 3 | AUD███.██ |
| Luxembourg | reimbursement | 3 | 3 | EUR███.██ |
| Iceland | max wholesale | 2 | 2 | ISK███.██ |
| Czechia | max producer price (ex-factory) | 1 | 1 | CZK███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
225 pack listings across 113 brand entries and 13 price bases, refreshed 08 Sep 2026. Ranges span every Lidocaine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Lidocaine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
64 holders have a Canadian DIN containing Lidocaine, across 120 DINs, of which 18 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ODAN LABORATORIES LTD | 6 | 3 | LIDODAN 4% TOPICAL SOLUTION, LIDODAN CREAM 4%, LIDODAN CREAM 5%, LIDODAN JELLY 2%, LIDODAN JELLY 2%(SINGLE USE SYRINGE), +1 more | Sourceable in Canada |
| WELLSPRING PHARMACEUTICAL CANADA CORP | 3 | 2 | BACTINE FIRST AID SPRAY, SOLARCAINE BURN PAIN RELIEF, SOLARCAINE FIRST AID LIDOCAINE SPRAY | Sourceable in Canada |
| RGR PHARMA LTD. | 2 | 2 | MAXILENE 4, MAXILENE 5 | Sourceable in Canada |
| SHINPHARMA INC | 2 | 2 | DR. NUMB, NUMBSKIN | Sourceable in Canada |
| THE MENTHOLATUM COMPANY OF CANADA LTD | 5 | 1 | LIDOCAINE, LIDOCAINE PLUS MENTHOL, MEDI-QUIK FIRST AID SPRAY, MEDI-QUIK FIRST-AID SPRAY - AER TOP | Sourceable in Canada |
| SCALP TECH INC. | 4 | 1 | BLACK LABEL ANORECTAL NUMBING SPRAY, GOLD LABEL ANORECTAL NUMBING SPRAY, LIDOCAINE ANORECTAL TEMPORARY PAIN RELIEF SPRAY, THE SOLUTION ANORECTAL SPRAY TEMPORARY PAIN RELIEF | Sourceable in Canada |
| QUEST PRODUCTS, LLC | 3 | 1 | ALOCANE, ALOCANE PLUS | Sourceable in Canada |
| ALERA SKIN CARE PRODUCTS INC. | 2 | 1 | NANONUMB, ZENSA | Sourceable in Canada |
| FRUIT OF THE EARTH, INC | 2 | 1 | AFTER SUN GEL, EQUATE AFTER SUN GEL WITH LIDOCAINE | Sourceable in Canada |
| HUMN PHARMACEUTICALS INC | 2 | 1 | BURN RELIEF CREAM, TPR20 | Sourceable in Canada |
| POUND INTERNATIONAL LTD. | 2 | 1 | PREMJACT, STUD 100 | Sourceable in Canada |
| ASPEN PHARMACARE CANADA INC. | 1 | 1 | XYLOCAINE OINTMENT 5% | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Lidocaine |
|---|---|
| ATC code | D04AB01 |
| AHFS class | 84:08.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02393344 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2393344 |
| Brand name | DERMATOLOGIC RELIEF |
| Generic / active ingredient | LIDOCAINE : 2 % ZINC OXIDE : 16 % |
| Market authorization holder | JAMP PHARMA CORPORATION |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D04AB01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D04AB |
| Current status | APPROVED |
| Status date | 11-Sep-2012 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Lidocaine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by HIKMA CANADA LIMITED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
18 of 120 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AFTER SUN GEL | 0.8 % | GEL | FRUIT OF THE EARTH, INC | MARKETED | 02499118 |
| ALOCANE PLUS | 4 % | GEL | QUEST PRODUCTS, LLC | MARKETED | 02552590 |
| BACTINE FIRST AID SPRAY | 2.5 % | SPRAY | WELLSPRING PHARMACEUTICAL CANADA CORP | MARKETED | 02150379 |
| DR. NUMB | 5 % | CREAM | SHINPHARMA INC | MARKETED | 02354527 |
| LIDOCAINE | 4 % | GEL | THE MENTHOLATUM COMPANY OF CANADA LTD | MARKETED | 02485311 |
| LIDODAN 4% TOPICAL SOLUTION | 4 % | SOLUTION | ODAN LABORATORIES LTD | MARKETED | 02419505 |
| LIDODAN JELLY 2% | 20 MG | JELLY | ODAN LABORATORIES LTD | MARKETED | 02143879 |
| LIDODAN OINTMENT 5% | 5 % | OINTMENT | ODAN LABORATORIES LTD | MARKETED | 02083795 |
| MAXILENE 4 | 4 % | CREAM | RGR PHARMA LTD. | MARKETED | 02244533 |
| MAXILENE 5 | 5 % | CREAM | RGR PHARMA LTD. | MARKETED | 02245939 |
2 · Same class — other molecules in ATC D04AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Lidocaine | 2025-04-15 00:00:00 · AFTER SUN BURN RELIEF LIDOCAINE CONTINUOUS SPRAY · AFTER SUN GEL · AFTER SUN SOOTHING SPRAY · +112 more | 120 | 18 | Yes |
| Pramocaine | AVEENO ANTI-ITCH CREAM · AVEENO ANTI-ITCH LOTION · BACTINE PAIN RELIEVING CLEANSING SPRAY · BIKINI ZONE MEDICATED AFTER SHAVE SPRAY · +26 more | 36 | 7 | Yes |
| Benzocaine | ANIVY · BALZAROL ONT · BITE RELIEF · BOIL EASE DRAWING SALVE ONT · +24 more | 28 | 2 | Yes |
| Topical Anesthetics, Combinations | BURNCARE KIT · CETACAINE SPRAY · DERMACAINE-R · ONE TOUCH TOPICAL ANESTHETIC GEL · +3 more | 7 | 2 | Yes |
| Tetracaine | AMETOP GEL 4% · TETRACAINE2 · VIRACTIN GEL · VIRACTIN MOISTURIZING CREAM | 4 | 1 | Yes |
| Lidocaine, Combinations | BURN RELIEF GEL · ICY HOT LIDOCAINE PAIN RELIEVING CREAM PLUS MENTHOL · ITCH RELIEF CREAM · PAIN RELIEVING CLEANSING SPRAY · +3 more | 7 | 0 | Not in Canada |
| Cinchocaine | NUPERCAINAL ANTISEPTIC CREAM | 1 | 0 | Not in Canada |
| Benzocaine, Combinations | KAMA SUTRA PLEASURE BALM | 1 | 0 | Not in Canada |
| Anesthetics For Topical Use | TANAC MEDICATED GEL | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D04A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D04AA | Diphenhydramine · Promethazine · Tripelennamine | 30 | 6 |
| D04AX | Other Antipruritics | 39 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is DERMATOLOGIC RELIEF called?
The same molecule, Lidocaine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Lignox | Latin | Saudi Arabia |
| VERSATIS | Latin | Bahrain, Czechia |
| Depo-medrol with Lidocaine | Latin | South Africa |
| Lidocaine Eva | Latin | Saudi Arabia |
| PLIAGLIS | Latin | Bahrain |
| Pliaglis® | Latin | United Arab Emirates |
| PRILA | Latin | Bahrain |
| Xylocaine | Latin | Bahrain, South Africa |
| xylocream® | Latin | United Arab Emirates |
| AVOCAINE | Latin | Bahrain |
| BelOcain vet. | Latin | Iceland |
| EMLA | Latin | Bahrain |
| Ennla | Latin | Saudi Arabia |
| Haemoproct | Latin | United Arab Emirates |
| Haemoproct Cream | Latin | United Arab Emirates |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.